7XP.MU Organon & Co.
- Market cap
- -
- P/E
- 18.4x
- P/B
- 3.03x
- ROE
- 50.5%
- Dividend yield
- -
- Fundamental score
- 1.6/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 7XP.MU undervalued?
Graham numberThe Graham number of Organon & Co. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Organon & Co. fundamental analysis
7 of 22 checks passedROE 2/2
High return on equity (50.5%), above 20%.
ROA 1/1
Return on assets (3.9%) is above the industry median (3.2%).
Profit Consistency 2/2
Profitable for 8 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-78.6%) is not above the 5-year average (-39.0% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-78.6%) is below the industry median (15.2%).
Revenue Growth 1/2
Revenue grew 0.2% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 0/2
High debt to equity (842.8%), above 100%.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 0/1
EBIT is 2.8x against interest expense, below 5x.
PE vs Market 0/1
PE (18.4x) is above the market median (16.6x).
PE vs Industry 0/1
PE (18.4x) is above the industry median (18.3x).
PBV 0/1
Price to book (3.0x) is above the industry median (1.9x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 55.7, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 1/2
Dividend yield (2.6%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 47.1%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Organon & Co. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Organon & Co. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Organon & Co. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 9.78B | 7.78B | 6.53B | 6.30B | 6.17B | 6.26B | 6.40B | 6.22B | 6.04B |
| Gross Profit | 5.08B | 5.50B | 4.41B | 3.92B | 3.88B | 3.75B | 3.72B | 3.31B | 3.26B |
| Operating Income | 2.71B | 3.84B | 2.85B | 1.92B | 1.71B | 1.33B | 1.49B | 1.23B | 1.18B |
| EBITDA | 4.38B | 4.03B | 2.94B | 1.81B | 1.76B | 1.44B | 1.60B | 1.29B | 1.56B |
| Net Income | 2.15B | 3.22B | 2.16B | 1.35B | 917M | 1.02B | 864M | 187M | 508M |
| EPS | - | 13 | 8.53 | 5.33 | 3.60 | 4.00 | 3.35 | 0.72 | 1.93 |
| Balance Sheet | |||||||||
| Total Assets | - | 10.5B | 10.1B | 10.7B | 11.0B | 12.1B | 13.1B | 12.9B | 13.2B |
| Total Liabilities | - | 3.51B | 4.62B | 12.2B | 11.8B | 12.1B | 12.6B | 12.1B | 12.2B |
| Shareholders' Equity | - | 7.04B | 5.49B | -1.51B | -892M | -70.0M | 472M | 752M | 1.01B |
| Cash & Short-term Investments | - | 319M | 12.0M | 737M | 706M | 693M | 675M | 574M | 1.13B |
| Cash Flow | |||||||||
| Operating Cash Flow | 3.69B | 2.77B | 2.19B | 2.46B | 858M | 799M | 939M | 700M | 664M |
| Capital Expenditure | 101M | 92.0M | 255M | 488M | 427M | 261M | 351M | 316M | 246M |
| Free Cash Flow | 3.59B | 2.68B | 1.93B | 1.97B | 431M | 538M | 588M | 384M | 418M |
| Ratios | |||||||||
| ROE | - | 45.7% | 39.4% | - | - | - | 183.1% | 24.9% | 50.5% |
| ROA | - | 30.5% | 21.4% | 12.6% | 8.4% | 8.5% | 6.6% | 1.5% | 3.9% |
| Net Profit Margin | 22.0% | 41.4% | 33.1% | 21.4% | 14.9% | 16.3% | 13.5% | 3.0% | 8.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Organon & Co. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- 47.1%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 88.0M | 0.34 | 47.1% |
| 2024 | USD 297M | 1.15 | 34.4% |
| 2023 | USD 294M | 1.15 | 28.7% |
| 2022 | USD 290M | 1.14 | 31.6% |
| 2021 | USD 145M | 0.57 | 10.7% |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Organon & Co.
Ownership data of Organon & Co. is not available yet.
Organon & Co. company profile
- Company name
- Organon & Co.
- Ticker
- 7XP.MU
- Exchange
- Munich Exchange
- Sector
- -
- Industry
- -
- Fiscal year end
- December
- Address
- Website
- -